Secreted Matrix Metalloproteinase-14 is a Predictor for Antifibrotic Effect of IC-2-engineered Mesenchymal Stem Cell Sheets on Liver Fibrosis in Mice

Overview

Journal Regen Ther

Date 2021 Sep 10

PMID 34504910

Citations 4

Authors

Kenji Fukushima

Noriko Itaba

Yohei Kono

Shizuma Okazaki

Shinpei Enokida

Naomi Kuranobu

Jun Murakami

Makoto Enokida

Hideki Nagashima

Susumu Kanzaki

Noriyuki Namba

Goshi Shiota

Affiliations

Soon will be listed here.

Abstract

Introduction: Transplantation of IC-2-engineered bone marrow-derived mesenchymal stem cell (BM-MSC) sheets (IC-2 sheets) was previously reported to potentially reduce liver fibrosis.

Methods: This study prepared IC-2-engineered cell sheets from multiple lots of BM-MSCs and examined the therapeutic effects of these cell sheets on liver fibrosis induced by carbon tetrachloride in mice. The predictive factors for antifibrotic effect on liver fibrosis were tried to identify in advance.

Results: Secreted matrix metalloproteinase (MMP)-14 was found to be a useful predictive factor to reduce liver fibrosis. Moreover, the cutoff index of MMP-14 for 30% reduction of liver fibrosis was 0.918 fg/cell, judging from univariate analysis and receiver operating curve analysis. In addition, MMP-13 activity and thioredoxin contents in IC-2 sheets were also inversely correlated with hepatic hydroxyproline contents. Finally, IC-2 was also found to promote MMP-14 secretion from BM-MSCs of elderly patients. Surprisingly, the values of secreted MMP-14 from BM-MSCs of elderly patients were much higher than those of young persons.

Conclusion: The results of this study suggest that the IC-2 sheets would be applicable to clinical use in autologous transplantation for patients with cirrhosis regardless of the patient's age.

Citing Articles

Mesenchymal stromal cells in hepatic fibrosis/cirrhosis: from pathogenesis to treatment.

Yang X, Li Q, Liu W, Zong C, Wei L, Shi Y Cell Mol Immunol. 2023; 20(6):583-599.

PMID: 36823236 PMC: 10229624. DOI: 10.1038/s41423-023-00983-5.

Intestinal Fibrosis in Inflammatory Bowel Disease and the Prospects of Mesenchymal Stem Cell Therapy.

Wang Y, Huang B, Jin T, Ocansey D, Jiang J, Mao F Front Immunol. 2022; 13:835005.

PMID: 35370998 PMC: 8971815. DOI: 10.3389/fimmu.2022.835005.

Regenerative Medicine Application of Mesenchymal Stem Cells.

Abatay Sel F, Savran Oguz F Adv Exp Med Biol. 2022; 1387:25-42.

PMID: 35334100 DOI: 10.1007/5584_2022_713.

Extracellular Matrix Synthesis and Remodeling by Mesenchymal Stromal Cells Is Context-Sensitive.

Burk J, Sassmann A, Kasper C, Nimptsch A, Schubert S Int J Mol Sci. 2022; 23(3).

PMID: 35163683 PMC: 8836208. DOI: 10.3390/ijms23031758.

References

Erices A, Conget P, Minguell J . Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109(1):235-42. DOI: 10.1046/j.1365-2141.2000.01986.x. View

Iseoka H, Miyagawa S, Saito A, Harada A, Sawa Y . Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model. Stem Cell Res Ther. 2020; 11(1):69. PMC: 7029551. DOI: 10.1186/s13287-020-1582-5. View

Cao W, Cao K, Cao J, Wang Y, Shi Y . Mesenchymal stem cells and adaptive immune responses. Immunol Lett. 2015; 168(2):147-53. DOI: 10.1016/j.imlet.2015.06.003. View

Mallat A, Lotersztajn S . Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis. Am J Physiol Cell Physiol. 2013; 305(8):C789-99. DOI: 10.1152/ajpcell.00230.2013. View

Ding D, Shyu W, Chiang M, Lin S, Chang Y, Wang H . Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis. 2007; 27(3):339-53. DOI: 10.1016/j.nbd.2007.06.010. View

Ge P, Runyon B . Treatment of Patients with Cirrhosis. N Engl J Med. 2016; 375(8):767-77. DOI: 10.1056/NEJMra1504367. View

Memon I, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S . Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. J Thorac Cardiovasc Surg. 2005; 130(5):1333-41. DOI: 10.1016/j.jtcvs.2005.07.023. View

Dotoli G, De Santis G, Orellana M, de Lima Prata K, Caruso S, Fernandes T . Mesenchymal stromal cell infusion to treat steroid-refractory acute GvHD III/IV after hematopoietic stem cell transplantation. Bone Marrow Transplant. 2017; 52(6):859-862. DOI: 10.1038/bmt.2017.35. View

Yoshida Y, Shimomura T, Sakabe T, Ishii K, Gonda K, Matsuoka S . A role of Wnt/beta-catenin signals in hepatic fate specification of human umbilical cord blood-derived mesenchymal stem cells. Am J Physiol Gastrointest Liver Physiol. 2007; 293(5):G1089-98. DOI: 10.1152/ajpgi.00187.2007. View

10.

Percie du Sert N, Hurst V, Ahluwalia A, Alam S, Avey M, Baker M . The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLoS Biol. 2020; 18(7):e3000410. PMC: 7360023. DOI: 10.1371/journal.pbio.3000410. View

11.

Lindsey M, Goshorn D, Squires C, Escobar G, Hendrick J, Mingoia J . Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res. 2005; 66(2):410-9. DOI: 10.1016/j.cardiores.2004.11.029. View

12.

Smejkalova J, Simek J, ROUCHAL J, DVORACKOVA I . The time course of biochemical and histological changes following carbon tetrachloride-induced liver damage in rats of both sexes. Physiol Bohemoslov. 1985; 34(6):494-501. View

13.

Kuo T, Hung S, Chuang C, Chen C, Shih Y, Fang S . Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology. 2008; 134(7):2111-21, 2121.e1-3. PMC: 3086672. DOI: 10.1053/j.gastro.2008.03.015. View

14.

Will H, Atkinson S, Butler G, Smith B, Murphy G . The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem. 1996; 271(29):17119-23. DOI: 10.1074/jbc.271.29.17119. View

15.

Itaba N, Sakabe T, Kanki K, Azumi J, Shimizu H, Kono Y . Identification of the small molecule compound which induces hepatic differentiation of human mesenchymal stem cells. Regen Ther. 2019; 2:32-41. PMC: 6581787. DOI: 10.1016/j.reth.2015.10.001. View

16.

Watanabe T, Niioka M, Ishikawa A, Hozawa S, Arai M, Maruyama K . Dynamic change of cells expressing MMP-2 mRNA and MT1-MMP mRNA in the recovery from liver fibrosis in the rat. J Hepatol. 2001; 35(4):465-73. DOI: 10.1016/s0168-8278(01)00177-5. View

17.

Wang S, Qu X, Zhao R . Clinical applications of mesenchymal stem cells. J Hematol Oncol. 2012; 5:19. PMC: 3416655. DOI: 10.1186/1756-8722-5-19. View

18.

Suk K, Yoon J, Kim M, Kim C, Kim J, Park H . Transplantation with autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: Phase 2 trial. Hepatology. 2016; 64(6):2185-2197. DOI: 10.1002/hep.28693. View

19.

Beste L, Leipertz S, Green P, Dominitz J, Ross D, Ioannou G . Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015; 149(6):1471-1482.e5. DOI: 10.1053/j.gastro.2015.07.056. View

20.

Zhang D, Friedman S . Fibrosis-dependent mechanisms of hepatocarcinogenesis. Hepatology. 2012; 56(2):769-75. PMC: 4087159. DOI: 10.1002/hep.25670. View